Study Stopped
Insufficient recruitment/data collection
Attention Bias Modification Treatment for Anxious Youth
ABMT
1 other identifier
interventional
5
1 country
2
Brief Summary
The purpose of this project is to study the feasibility and efficacy of attention bias modification treatment (ABMT) in a randomized-controlled sample of anxious youth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2013
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2013
CompletedStudy Start
First participant enrolled
October 1, 2013
CompletedFirst Posted
Study publicly available on registry
November 8, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 17, 2017
CompletedJuly 30, 2019
July 1, 2019
3.3 years
September 30, 2013
July 29, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in clinical severity ratings on Anxiety Disorder Interview Schedule-Child and Parent Version
after a 6-week intervention and 4-week no-treatment follow-up
Secondary Outcomes (1)
Variation in genes associated with treatment response
week 1
Study Arms (2)
Attention Bias Modification
ACTIVE COMPARATORAttention Bias Modification computer task
Placebo Computer Task
PLACEBO COMPARATORPlacebo computer task
Interventions
Computer task aimed at actively modifying attention bias
Computer task that does not actively modify attention bias
Eligibility Criteria
You may qualify if:
- Diagnosis on Anxiety Disorders Interview Schedule for Diagnostic and Statistical Manual-IV Child and Parent versions of Separation Anxiety Disorder, Social Phobia, Specific Phobia, Obsessive-Compulsive Disorder, or Generalized Anxiety Disorder
- Age 7 to 17
You may not qualify if:
- Posttraumatic stress disorder or primary diagnosis of major depressive disorder
- Seizure disorder
- Current treatment with psychotropic medication
- Multiple chronic learning disabilities and/or conduct problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Payne Whitney Manhattan Child Division
New York, New York, 10065, United States
New York Presbyterian Hospital--Westchester Division
White Plains, New York, 10605, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Megan H Feltenberger, PhD
Weill Medical College of Cornell University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2013
First Posted
November 8, 2013
Study Start
October 1, 2013
Primary Completion
January 17, 2017
Study Completion
January 17, 2017
Last Updated
July 30, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will share